Zevra Therapeutics, Inc. (ZVRA)
(Real Time Quote from BATS)
$4.79 USD
-0.10 (-2.05%)
Updated May 14, 2024 02:46 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 18.37% |
ABR | 1.00 |
Earnings ESP
|
-0.76% |
---|---|
Current Year | -1.57 |
Next Year | -0.17 |
EPS (TTM) | -1.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.43M | 5.54M | 28.77M | 108.47M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 4.65M | 5.93M | 37.91M | 141.31M |
Low Estimate | 4.10M | 5.20M | 22.70M | 85.20M |
Year ago Sales | 8.47M | 2.90M | 27.46M | 28.77M |
Year over Year Growth Est. | -47.70% | 91.14% | 4.75% | 277.09% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.43 | -1.57 | -0.17 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.44 | -0.41 | -1.31 | -0.24 |
High Estimate | -0.43 | -0.41 | -1.31 | 0.49 |
Low Estimate | -0.44 | -0.45 | -1.73 | -0.77 |
Year ago EPS | -0.15 | -0.40 | -1.30 | -1.57 |
Year over Year Growth Est. | -193.33% | -7.50% | -20.77% | 88.80% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 2 | 1 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 3 | 3 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.43 | -1.57 | -0.17 |
7 Days Ago | -0.45 | -0.45 | -1.65 | -0.18 |
30 Days Ago | -0.45 | -0.44 | -1.65 | -0.16 |
60 Days Ago | -0.38 | -0.38 | -1.28 | 0.06 |
90 Days Ago | -0.37 | -0.11 | -1.03 | 0.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.43 | -1.57 | -0.51 |
Zacks Consensus Estimate | -0.44 | -0.43 | -1.57 | -0.17 |
Earnings ESP | -0.76% | 1.92% | -0.37% | -191.35% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.40 | -0.40 | -0.15 | NA |
Estimate | -0.49 | -0.20 | -0.29 | -0.39 | NA |
Difference | 0.09 | -0.20 | -0.11 | 0.24 | 0.01 |
Surprise | 18.37% | -100.00% | -37.93% | 61.54% | -14.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more